官方微信|手機版|本站服務|買家中心|行業(yè)動態(tài)|幫助

產(chǎn)品|公司|采購|招標

英國NIBSC標準物質

參考價面議
具體成交價以合同協(xié)議為準
  • 公司名稱上??戮S化學技術有限公司
  • 品       牌
  • 型       號
  • 所  在  地上海市
  • 廠商性質代理商
  • 更新時間2017/9/28 16:08:52
  • 訪問次數(shù)1597
在線詢價 收藏產(chǎn)品 查看電話 同類產(chǎn)品

聯(lián)系我們時請說明是 制藥網(wǎng) 上看到的信息,謝謝!

我司主要供應產(chǎn)品:

1 法定藥典標準品(如中檢所、美國中草藥標準品ChromaDex、USP、EP、BP、JP等),

2 其它標準品(如美國標準局NIST、歐洲標準局IRRM、美國聚合物標準品APSC、同位素標準品Omicron等)

3 藥物代謝雜質類產(chǎn)品(如英國LGC,加拿大TRC,TLC等),

4 常用化學試劑(如脂質類試劑,同位素試劑,Sigma,TCI,中檢所培養(yǎng)基,進口培養(yǎng)基等)

5 定制各種法定藥典外藥物雜質(附COA及H-NMR,MS,HPLC圖譜),

6  各*試劑:阿拉丁、麥克林、Sigma

 

貨期準,到貨快,價格優(yōu)。歡迎來電垂詢!

 

法定藥典標準品(如中檢所、美國中草藥標準品ChromaDex、USP、EP、BP、JP等),藥物代謝雜質類產(chǎn)品(如英國LGC,加拿大TRC,TLC等)
英國NIBSC標準物質 上海柯維化學優(yōu)惠供應中
NIBSC種類繁多,由于網(wǎng)頁排版只列舉其中一部分產(chǎn)品,更多產(chǎn)品信息詳詢。
英國NIBSC標準物質 產(chǎn)品信息

上??戮S化學供應英國NIBSC標準品,美國 ATCC菌株,中檢所CMCC菌種,歡迎訂購。
多種規(guī)格型號可供選擇,定量質控菌株,定性質控菌株,單一菌株,菌株套裝等,使用方便,滿足您的實驗需求。

04/172    Influenza Virus infectious IVR-139
Influenza Reagent
04/176    Plasmodium falciparum DNA for NAT Assays(1st International Standard)
WHO International Standard
04/198    Anti-Meningococcal Serotype P3.1 mAb
Non WHO Reference Material
04/200    Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)
WHO International Standard
04/202    Influenza Antigen B/ Jiangsu/10/2003
Influenza Reagent
04/214    Influenza Antiserum A/Viet Nam/1194/04 (H5N1)
Influenza Reagent
04/224    Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
WHO International Standard
04/228    Influenza anti B/ Neuraminidase Serum
Influenza Reagent
04/242    Influenza anti B/Jiangsu/10/2003 HA Serum
Influenza Reagent
04/246    Anti-Meningococcal Serogroup W-135 mAb
Non WHO Reference Material
04/248    Anti-Meningococcal Serosubtype P1.19 mAb
Non WHO Reference Material
04/252    Protein C Concentrate, Human(1st International Standard)
WHO International Standard
04/260    Influenza anti A/New Caledonia/20/99 HA Serum
Influenza Reagent
04/262    Influenza anti A/New York/55/2004 HA Serum
Influenza Reagent
04/264    Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
Influenza Reagent
05/102    Influenza Virus infectious NYMC BX-7
Influenza Reagent
05/106    Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
International Reference Reagent
05/110    Influenza Virus infectious A/California/7/2004
Influenza Reagent
05/112    Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
WHO International Standard
05/122    Syphilitic plasma IgG (human)(1st International Standard)
WHO International Standard
05/130    Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
WHO International Standard
05/132    Syphilitic plasma IgG and IgM (human)(1st International Standard)
WHO International Standard
05/134    Anti-human papillomavirus type 16 serum (1st International Standard)
WHO International Standard
05/138    Influenza Virus infectious B/Shanghai/361/2002
Influenza Reagent
05/162    Alpha-1-Antitrypsin, plasma derived(1st International standard)
WHO International Standard
05/190    Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
Non WHO Reference Material
05/192    Anti Meningococcal Serotype P2.2b Monoclonal Antibody
Non WHO Reference Material
05/234    Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
Influenza Reagent
05/236    Influenza anti A/Wisconsin/67/2005 Serum
Influenza Reagent
05/242    IVIG, Anti-D and Negative Control Panel
Non WHO Reference Material
05/252    Influenza anti B Neuraminidase Serum
Influenza Reagent
06/108    Influenza Virus infectious IVR-116
Influenza Reagent
06/114    Influenza Virus Infectious A/PR/8/34
Influenza Reagent
06/124    Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 (1st International Standard)
WHO International Standard
06/128    Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 (1st International Standard)
WHO International Standard
06/140    Pertussis Antiserum(human)1st IS-WHO international Standard.
WHO International Standard
06/142    Pertussis Antiserum (Human) 1st WHO Reference Reagent
International Reference Reagent
06/164    Influenza Virus infectious 1 VR-142
Influenza Reagent
06/166    Antithrombin Concentrate, Human (3rd International Standard)
WHO International Standard
06/170    Influenza Antigen A/New Caledonia/20/99
Influenza Reagent
06/192    Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
Influenza Reagent
06/202    Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
WHO International Standard
06/206    Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
WHO International Standard
06/242    Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)
Influenza Reagent
07/102    Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)
Influenza Reagent
07/104    Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum
Influenza Reagent
07/112    Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
Influenza Reagent
07/132    Influenza Virus infectious B/Malaysia/2506/2004
Influenza Reagent
07/144    Influenza Virus infectious IVR-145,
Influenza Reagent
07/146    Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)
Influenza Reagent
07/148    Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
Influenza Reagent
07/150    Human Plasma Anti-Influenza H5N1 (1st International Standard)
WHO International Standard
07/164    Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
WHO International Standard
07/184    Influenza anti B/Malaysia/2506/2004-HA Serum
Influenza Reagent
07/202    Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
International Reference Reagent
07/204    Influenza Virus Infectious NIBRG-60 VE2 25820
Influenza Reagent
07/214    Positive Control for use in flow cytometry cross matching (FCXM)
CE Marked Material
07/216    Diphtheria Toxoid (Adsorbed) (4th International Standard)
WHO International Standard
07/222    RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)
International Reference Reagent
07/226    Influenza Virus Infectious A/New Caledonia/20/99
Influenza Reagent
07/228    Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
WHO International Standard
07/246    Influenza Virus Infectious IVR-147
Influenza Reagent
07/268    Influenza Virus Infectious B/Brisbane/3/2007
Influenza Reagent
07/270    BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
International Reference Reagent
07/272    BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
International Reference Reagent
07/274    BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
International Reference Reagent
07/278    Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
Influenza Reagent
07/286-014    0.05 IU HBsAg Monitor Sample
CE Marked Material
07/288-016    Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml
CE Marked Material
07/290    Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
Influenza Reagent
07/294-006    Norovirus GII for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/296-006    Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/298-006    Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/300-005    Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/304    Anti-D for assuring operator and test performance
Working Standard
07/306    Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)
International Reference Reagent
07/316    Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
WHO International Standard
07/318    Meningococcal Group C Polysaccharide
Non WHO Reference Material
07/326    Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.
Working Standard
07/328    Unfractionated Heparin (6th I.S.)
WHO International Standard
07/336    Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
Influenza Reagent
07/338    Influenza antiserum A/Anhui/1/05 (H5)
Influenza Reagent
07/348    Influenza Virus infectious NYMC X-171B
Influenza Reagent
07/350    Blood Coagulation Factor VIII Concentrate (8th I.S.)
WHO International Standard
07/358    Influenza Virus infectious NIB-50
Influenza Reagent
07/362    Influenza Virus infectious IVR-149
Influenza Reagent
07/364    Chorionic Gonadotrophin, (5th International Standard)
WHO International Standard
07/B498-18    QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
Quality Control Reagent
08/100    Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
Influenza Reagent
08/108    Influenza Virus Infectious NIBRG-91
Influenza Reagent
08/118-005    Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/120-005    Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/126    Influenza Anti N1 Neuraminidase Serum SH485
Influenza Reagent
08/138    Influenza Virus Infectious B/Florida/4/2006
Influenza Reagent
08/140    Influenza Antigen B/Florida/4/2006
Influenza Reagent
08/142    Influenza antiserum A/Anhui/1/05 (H5)
Influenza Reagent
08/148    Positive control for Luminex based anti-HLA Class II serology
CE Marked Material
08/150    HIV-2 RNA(1st International Standard)
WHO International Standard
08/154    Influenza Virus Infectious NIBRG-12
Influenza Reagent
08/156    Influenza Virus Infectious NIBRG-23 30060 VE3
Influenza Reagent
08/158    Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
WHO International Standard
08/160    Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
WHO International Standard
08/176-005    Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/178-005    Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/180-005    Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/184    Influenza Antigen B/Malaysia/2506/2004
Influenza Reagent
08/202    Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
Influenza Reagent
08/204    Thyroid Stimulating Antibody (2nd I.S.)
WHO International Standard
08/208    Influenza Antigen Hong Kong/1073/99 (H9N2)
Influenza Reagent
08/210    Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
Influenza Reagent
08/214    Meningococcal Serogroup C polysaccharide (1st International Standard)
WHO International Standard
08/216    Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)
Influenza Reagent
08/218    Tetanus Toxoid Adsorbed (4th International Standard)
WHO International Standard
08/228    Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
Influenza Reagent
08/230    Streptodornase (2nd International Standard)
WHO International Standard
08/246    Influenza anti A/Brisbane/10/2007- like HA serum
Influenza Reagent
08/256    C1- Inhibitor, Concentrate (1st International Standard)
WHO International Standard
08/258    Antithrombin, Plasma (3rd International Standard)
WHO International Standard
08/262    C1 Inhibitor (Plasma)(1st International Standard)
WHO International Standard
08/266    Sex Hormone Binding Globulin.(2nd International Standard)
WHO International Standard
08/268    Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
Influenza Reagent
08/278    Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
Influenza Reagent
08/282    Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
WHO International Standard
08/298    Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
Influenza Reagent
08/300    Influenza Virus Infectious IVR-148
Influenza Reagent

關鍵詞:標準品
在找 英國NIBSC標準物質 產(chǎn)品的人還在看

提示

×

*您想獲取產(chǎn)品的資料:

以上可多選,勾選其他,可自行輸入要求

個人信息: